Article

MI and Perhaps Stroke Risk Increased in Sjögren Syndrome

(EULAR 2014) A large population-based study from Canada finds the risk of myocardial infarction more than tripled in the first year after a Sjögren syndrome diagnosis, and a trend for increased stroke risk.

A retrospective matched-cohort study from Canada has found the risk of myocardial infarction (MI) substantially increased during the first year after diagnosis of Sjögren syndrome, and a trend for increased risk of stroke. The risk for both conditions remains doubled at three-years post-diagnosis, according to these data.

[[{"type":"media","view_mode":"media_crop","fid":"25154","attributes":{"alt":"","class":"media-image","height":"163","id":"media_crop_3098481128543","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2255","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"Risk of cardiovascular events after Sjögren syndrome diagnosis","typeof":"foaf:Image","width":"344"}}]]

The study by Marko Yurkovich MD of the University of British Columbia and coworkers at the Arthritis Research Centre of Canada headed Antonio Avina-Zubieta MD amassed records separately for the analysis of MI and cerebrovascular accident (CVA) risk, comparing cohorts of 1,176 and 1,195 patients diagnosed with Sjögren syndrome for subsequent MI and CVA events, respectively, against records for nearly 12,000 otherwise similar people who did not have Sjögren syndrome.

This is the first population-based study to address the question of cardiovascular risk in Sjögren syndrome, Yurkovich said at 2014 annual meeting of the European Union League Against Rheumatism (EULAR). The notably increased risk for MI in the first year after diagnosis indicates that the acute inflammatory state is probably the driver for the MI risk, he added.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.